More tools:Markets·Screener·Research Chat

Aflac Inc. (AFL) Financial Statements

Aflac Inc.
SIC 6321 · ACCIDENT & HEALTH INSURANCE
FIGI BBG001S5NGJ4
XNYS · usd
122.05▼ 1.25 (-1.01%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)$18.1B
Net Income (TTM)$4.6B
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close123.30
Day's Range122.02 – 123.75
52-Week Range96.95 – 124.00
Volume1.73M
Avg Volume2.49M
Share Statistics
Shares Outstanding509.0M
Employees12.7K
ExchangeXNYS
Listed1973-08-27

Key questions about Aflac Inc. (AFL)

What is Aflac Inc.'s Market Cap?
Aflac Inc.'s Market Cap is $62.1B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Enterprise Value?
Aflac Inc.'s Enterprise Value is $62.8B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Trailing P/E?
Aflac Inc.'s Trailing P/E is 13.4×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Price / Sales?
Aflac Inc.'s Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s EV / Revenue?
Aflac Inc.'s EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Revenue (TTM)?
Aflac Inc.'s Revenue (TTM) is $18.1B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Net Income (TTM)?
Aflac Inc.'s Net Income (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Diluted EPS (TTM)?
Aflac Inc.'s Diluted EPS (TTM) is 9.11, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Net Debt?
Aflac Inc.'s Net Debt is $0.00, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenues:
Net investment income
Net investment gains (losses)
Other income (loss)
Total revenues
YoY growth+27.9%-9.9%+60.7%-19.0%
Benefits and expenses:
Benefits and claims, excluding reserve remeasurement
Reserve remeasurement (gains) losses
Total benefits and claims, net
Acquisition and operating expenses:
Amortization of deferred policy acquisition costs
Insurance commissions
Insurance and other expenses
Interest expense
Total acquisition and operating expenses
% of revenue29.7%28.6%27.6%31.9%
Total benefits and expenses
Earnings before income taxes
Income taxes
Net earnings
% of revenue23.4%28.3%34.6%14.4%
Net earnings per share:
Basic
Diluted
Weighted-average outstanding common shares used in computing earnings per share (In thousands):
Basic
Diluted
Cash dividends per share————